查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866561

临床营养市场－2025-2030年预测

Clinical Nutrition Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

临床营养市场预计将从 2025 年的 587.88 亿美元成长到 2030 年的 893.38 亿美元，复合年增长率为 8.73%。

临床营养市场正经历显着成长，这主要得益于人们对使用专业产品解决营养缺乏和代谢紊乱问题的需求日益增长。这些产品包括维生素、蛋白质、矿物质和膳食补充剂，旨在维持营养平衡，尤其适用于慢性病患者。由于糖尿病和癌症等代谢紊乱的发病率不断上升，以及营养不良和肥胖率的增加，预计该市场将从2023年起持续成长。全球人口老化，尤其是老年人更容易面临代谢和营养的挑战，也进一步推动了对临床营养解决方案的需求。

临床营养涵盖多种产品，包括用于治疗目的的肠外营养和经肠营养营养，这些产品需要获得政府核准；以及无需监管部门批准的膳食补充剂（特殊医学用途配方食品）。这些产品对于疾病管理至关重要，它们能够为营养不良、代谢紊乱和其他健康问题提供个人化的营养支持。关键成长要素包括需要特殊营养介入的慢性疾病的增加，以及全球营养不良负担的日益加重，尤其是在食物供应有限的地区。此外，老年人更容易出现营养缺乏也是推动市场扩张的因素，而临床营养产品正是为了应对与老龄化相关的代谢挑战而开发的。

然而，也存在一些局限性，例如对治疗性营养产品严格的法规结构，这会延缓产品上市并增加合规成本。此外，消费者和医疗保健提供者对临床营养益处的认识不足也阻碍了其广泛应用。另一个挑战是缺乏先进的分析技术来全面检验营养缺乏，这限制了个人化营养解决方案的准确性。

按地区划分，北美和欧洲占据了相当大的市场份额，这主要得益于其先进的医疗保健体係以及人们对临床营养在患者照护中作用的高度重视。亚太地区正崛起为重要的成长区域，这主要得益于医疗保健投资的增加和慢性病盛行率的上升。监管政策，尤其是在已开发市场，正在影响产品开发，而为确保安全性和有效性而製定的严格标准也增加了製造商的营运复杂性。

竞争情报涵盖了贝朗主要企业（B. Braun Melsungen AG）、斯捷潘公司（Stepan Company）、雀巢健康科学（Nestle Health Science）、百特（Baxter）、雅培（Abbott）、Filament BioSolutions Inc.、纽崔斯（NUTRICIA）、费森尤斯卡比（Fresenius Kabi）、美赞臣营养品公司（Mead Johnson Nutrition Company）和佩里戈营养品公司（Perrigo Nutritionals）等主要企业。这些公司正致力于创新，开发先进的营养配方，并透过策略伙伴关係拓展市场份额。市场分析基于行业报告和相关人员的回馈，采用自下而上和自上而下的方法预测需求、供应和销售趋势。数据三角验证确保了洞察的准确性，而图表则有助于增强相关人员的理解。

受日益严峻的健康挑战、人口老化以及对专业营养解决方案需求不断增长的推动，临床营养市场预计将在2023年至2025年间保持强劲增长。儘管监管障碍和认知差距依然存在，但持续创新和医疗保健覆盖范围的扩大将推动市场持续扩张。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 依产品类型分類的临床营养市场

  • 介绍
  • 经肠营养
  • 肠外营养
  • 婴儿营养
  • 特殊医学食品
  • 补充

6. 依给药途径分類的临床营养市场

  • 介绍
  • 口服
  • 肠内营养
  • 静脉

7. 按治疗领域分類的临床营养市场

  • 介绍
  • 瘤
  • 代谢性疾病
  • 胃肠道疾病
  • 神经系统疾病
  • 慢性肾臟病
  • 儿童和新生儿
  • 加护治疗和术后康復
  • 其他的

第八章：按使用者类型分類的临床营养市场

  • 介绍
  • 儿童
  • 成人
  • 老年人

9. 按最终用户分類的临床营养市场

  • 介绍
  • 医院和诊所
  • 居家医疗
  • 长期照护机构
  • 专科门诊

第十章：按地区分類的临床营养市场

  • 介绍
  • 北美洲
    • 依产品类型
    • 透过行政途径
    • 按治疗区域
    • 依使用者类型
    • 最终用户
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型
    • 透过行政途径
    • 按治疗区域
    • 依使用者类型
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型
    • 透过行政途径
    • 按治疗区域
    • 依使用者类型
    • 最终用户
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 义大利
      • 其他的
  • 中东和非洲
    • 依产品类型
    • 透过行政途径
    • 按治疗区域
    • 依使用者类型
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依产品类型
    • 透过行政途径
    • 按治疗区域
    • 依使用者类型
    • 最终用户
    • 按国家/地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 台湾
      • 其他的

第十一章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十二章：公司简介

  • B. Braun Melsungen AG
  • Stepan Company
  • Nestle Health Science
  • Baxter International Inc.
  • Abbott
  • Filament BioSolutions Inc.
  • Danone SA
  • Fresenius Kabi AG
  • Mead Johnson Nutrition Company（Reckitt Benckiser Group Plc）
  • Perrigo Nutritionals
  • Pfizer
  • Dsm-Firmenich
  • Ajinomoto

第十三章 分析方法

简介目录
Product Code: KSI061612085

The Clinical Nutrition Market will surge from USD 58.788 billion in 2025 to USD 89.338 billion by 2030, registering a 8.73% CAGR.

The clinical nutrition market is experiencing significant growth, driven by the increasing need to address nutritional deficiencies and metabolic disorders through specialized products. These products, including vitamins, proteins, minerals, and dietary supplements, are designed to maintain nutritional balance in patients, particularly those with chronic conditions. Since 2023, the market has been propelled by rising incidences of metabolic disorders such as diabetes and cancer, alongside growing malnutrition and obesity rates. The aging global population, particularly susceptible to metabolic and nutritional challenges, further fuels demand for clinical nutrition solutions.

Clinical nutrition encompasses a range of products, including parenteral and enteral nutrition, which require government approval due to their therapeutic applications, and medical foods used for nutritional support, which do not need regulatory clearance. These products are critical in managing conditions like malnutrition, metabolic disorders, and other health challenges by providing tailored nutritional support. Key growth drivers include the increasing prevalence of chronic diseases, which necessitate specialized nutritional interventions, and the rising global burden of malnutrition, particularly in regions with limited access to adequate diets. The geriatric population's vulnerability to nutritional deficiencies also drives market expansion, as clinical nutrition products address age-related metabolic challenges.

However, the market faces restraints, including stringent regulatory frameworks governing therapeutic nutrition products, which can delay product launches and increase compliance costs. Additionally, limited awareness of clinical nutrition's benefits among consumers and healthcare providers hinders adoption. The lack of advanced analytical technologies to fully validate nutritional deficiencies also poses challenges, as it limits the precision of tailored nutrition solutions.

Geographically, North America and Europe hold significant market shares, driven by advanced healthcare systems and high awareness of clinical nutrition's role in patient care. Asia-Pacific is emerging as a key growth region, fueled by rising healthcare investments and increasing chronic disease prevalence. Regulatory policies, particularly in developed markets, shape product development, with stringent standards ensuring safety and efficacy but also increasing operational complexities for manufacturers.

Competitive intelligence highlights major players such as B. Braun Melsungen AG, Stepan Company, Nestle Health Science, Baxter, Abbott, Filament BioSolutions Inc., NUTRICIA, Fresenius Kabi, Mead Johnson Nutrition Company, and Perrigo Nutritionals. These companies are investing in innovation to develop advanced nutritional formulations and expand their market presence through strategic partnerships. Market analysis, derived from industry reports and stakeholder inputs, employs bottom-up and top-down approaches to forecast demand, supply, and sales trends. Data triangulation ensures accurate insights, with charts and graphs enhancing stakeholder understanding.

From 2023 to 2025, the clinical nutrition market is poised for robust growth, driven by rising health challenges, an aging population, and increasing demand for specialized nutritional solutions. Regulatory hurdles and awareness gaps remain challenges, but ongoing innovations and expanding healthcare access position the market for sustained expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product Type

  • Enteral Nutrition
  • Parenteral Nutrition
  • Infant Nutrition
  • Medical Foods
  • Supplements

By Route of Administration

  • Oral
  • Enteral
  • Parental

By Therapeutic Area

  • Oncology
  • Metabolic Diseases
  • Gastrointestinal (GI) Diseases
  • Neurological Disorders
  • Chronic Kidney Disease
  • Pediatric and Neonatal
  • Critical Care & Surgery Recovery
  • Others

By User Type

  • Pediatric
  • Adult
  • Geriatric

By End-User

  • Hospitals & Clinics
  • Homecare Settings
  • Long-term Care Facilities
  • Outpatient Specialty Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CLINICAL NUTRITION MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Enteral Nutrition
  • 5.3. Parenteral Nutrition
  • 5.4. Infant Nutrition
  • 5.5. Medical Foods
  • 5.6. Supplements

6. CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION

  • 6.1. Introduction
  • 6.2. Oral
  • 6.3. Enteral
  • 6.4. Parental

7. CLINICAL NUTRITION MARKET BY THERAPEUTIC AREA

  • 7.1. Introduction
  • 7.2. Oncology
  • 7.3. Metabolic Diseases
  • 7.4. Gastrointestinal (Gi) Diseases
  • 7.5. Neurological Disorders
  • 7.6. Chronic Kidney Disease
  • 7.7. Pediatric and Neonatal
  • 7.8. Critical Care & Surgery Recovery
  • 7.9. Others

8. CLINICAL NUTRITION MARKET BY USER TYPE

  • 8.1. Introduction
  • 8.2. Pediatric
  • 8.3. Adult
  • 8.4. Geriatric

9. CLINICAL NUTRITION MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Homecare Settings
  • 9.4. Long-term Care Facilities
  • 9.5. Outpatient Specialty Centers

10. CLINICAL NUTRITION MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. By Product Type
    • 10.2.2. By Route of Administration
    • 10.2.3. By Therapeutic Area
    • 10.2.4. By User Type
    • 10.2.5. By End-User
    • 10.2.6. By Country
      • 10.2.6.1. United States
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. By Product Type
    • 10.3.2. By Route of Administration
    • 10.3.3. By Therapeutic Area
    • 10.3.4. By User Type
    • 10.3.5. By End-User
    • 10.3.6. By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Others
  • 10.4. Europe
    • 10.4.1. By Product Type
    • 10.4.2. By Route of Administration
    • 10.4.3. By Therapeutic Area
    • 10.4.4. By User Type
    • 10.4.5. By End-User
    • 10.4.6. By Country
      • 10.4.6.1. United Kingdom
      • 10.4.6.2. Germany
      • 10.4.6.3. France
      • 10.4.6.4. Italy
      • 10.4.6.5. Others
  • 10.5. Middle East & Africa
    • 10.5.1. By Product Type
    • 10.5.2. By Route of Administration
    • 10.5.3. By Therapeutic Area
    • 10.5.4. By User Type
    • 10.5.5. By End-User
    • 10.5.6. By Country
      • 10.5.6.1. Saudi Arabia
      • 10.5.6.2. UAE
      • 10.5.6.3. Others
  • 10.6. Asia Pacific
    • 10.6.1. By Product Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Therapeutic Area
    • 10.6.4. By User Type
    • 10.6.5. By End-User
    • 10.6.6. By Country
      • 10.6.6.1. Japan
      • 10.6.6.2. China
      • 10.6.6.3. India
      • 10.6.6.4. South Korea
      • 10.6.6.5. Taiwan
      • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. B. Braun Melsungen AG
  • 12.2. Stepan Company
  • 12.3. Nestle Health Science
  • 12.4. Baxter International Inc.
  • 12.5. Abbott
  • 12.6. Filament BioSolutions Inc.
  • 12.7. Danone S.A.
  • 12.8. Fresenius Kabi AG
  • 12.9. Mead Johnson Nutrition Company (Reckitt Benckiser Group Plc)
  • 12.10. Perrigo Nutritionals
  • 12.11. Pfizer
  • 12.12. Dsm-Firmenich
  • 12.13. Ajinomoto

13. RESEARCH METHODOLOGY